The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol

Amalio Telenti, Wolfgang J. Philipp, Srinand Sreevatsan, Claudia Bernasconi, Kathryn E. Stockbauer, Brigitte Wieles, James M. Musser, William R. Jacobs

Research output: Contribution to journalArticlepeer-review

384 Scopus citations


Ethambutol (EMB), a frontline antituberculous drug, targets the mycobacterial cell wall, a unique structure among prokaryotes which consists of an outer layer of mycolic acids covalently bound to peptidoglycan via the arabinogalactan. EMB inhibits the polymerization of cell wall arabinan, and results in the accumulation of the lipid carrier decaprenol phosphoarabinose, which suggests that the drug interferes with the transfer of arabinose to the cell wall acceptor. Unfortunately, resistance to EMB has been described in up to 4% of clinical isolates of Mycobacterium tuberculosis and is prevalent among isolates from patients with multidrug-resistant tuberculosis. We used resistance to EMB as a tool to identify genes participating in the biosynthesis of the mycobacterial cell wall. This approach led to the identification of the embCAB gene cluster, recently proposed to encode for mycobacterial arabinosyl transferases. Resistance to EMB results from an accumulation of genetic events determining overexpression of the Emb protein(s), structural mutation in EmbB, or both. Further characterization of these proteins might provide information on targets for new chemotherapeutic agents and might help development of diagnostic strategies for the detection of resistant M. tuberculosis.

Original languageEnglish (US)
Pages (from-to)567-570
Number of pages4
JournalNature Medicine
Issue number5
StatePublished - 1997

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)


Dive into the research topics of 'The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol'. Together they form a unique fingerprint.

Cite this